# Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic

> **NCT00950222** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 70 (actual)

## Conditions studied

- Ventilator Associated Pneumonia

## Interventions

- **DRUG:** Imipenem/Amikacin

## Key facts

- **NCT ID:** NCT00950222
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2011-09
- **Final completion:** 2012-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2012-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00950222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00950222, "Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00950222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*